Drug Disposition Scholarly Journal
During the last decade, the appliance of
pharmacokinetic and pharmacodynamics modeling techniques has become an increasingly important aspect of up to date clinical
psychopharmacology (1–5). These techniques are applied during the method of development of latest drug entities also as for the improved understanding of the clinical actions of medicine that are already marketed. Techniques for the study of drug metabolism in vitro have advanced substantially during the last decade, and now are an integral component of preclinical
drug development and therefore the link to subsequent clinical studies of drug metabolism and disposition. Kinetic-dynamic modelling techniques are combined with in vitro metabolism procedures and in vitro–in vivo mathematical scaling models to supply insight into the overall problem of
pharmacokinetic drug interactions in clinical
psychopharmacology .
This chapter reviews some advances in pharmacokinetics, pharmacodynamics, and drug metabolism, along side methodological applications to chose problems in clinical psychopharmacology
Pharmacokinetic studies supported a standard intensive design
model are usually conducted using carefully selected volunteer subjects, a controlled experimental design, and collection of multiple blood samples. After measurement of drug and metabolite concentrations altogether samples, pharmaD. J. Greenblatt, L. L. von Moltke, J. S. Harmatz, and R. I. Shader: Department of
Pharmacology and Experimental Therapeutics, Tufts University School of
drugs , and Division of Clinical Pharmacology, New England Medical Centre, Boston, Massachusetts. Cokinetic models are applied to determine parameters such as
elimination half-life, volume of distribution, and clearance. During the new
drug development process, a series of
pharmacokinetic studies are conducted to determine the influence of major disease states or experimental conditions hypothesized to affect drug disposition. Such factors might include age, gender, body weight, ethnicity, hepatic and renal disease,
administration of food, and various drug interactions
High Impact List of Articles
-
Magnetic resonance imaging fatty liver changes following surgical, lifestyle or drug treatments in obese, non-alcoholic
fatty liver disease or non-alcoholic steatohepatitis subjects
Mark W Tengowski*, Thomas Fuerst & Claude B Sirlin
Review Article: Imaging in Medicine
-
Magnetic resonance imaging fatty liver changes following surgical, lifestyle or drug treatments in obese, non-alcoholic
fatty liver disease or non-alcoholic steatohepatitis subjects
Mark W Tengowski*, Thomas Fuerst & Claude B Sirlin
Review Article: Imaging in Medicine
-
News & Views in ... Imaging in Medicine 4:4
anonymous
News and Views: Imaging in Medicine
-
News & Views in ... Imaging in Medicine 4:4
anonymous
News and Views: Imaging in Medicine
-
MRI appearances of tuberculous meningitis in HIV-infected children: a paradoxically protective mechanism?
Savvas Andronikou, Nishentha Govender, Arhana Ramdass and Ronald van Toorn
Perspective: Imaging in Medicine
-
MRI appearances of tuberculous meningitis in HIV-infected children: a paradoxically protective mechanism?
Savvas Andronikou, Nishentha Govender, Arhana Ramdass and Ronald van Toorn
Perspective: Imaging in Medicine
-
Update on liver MRI at 3T
Sriyesh Krishnan and Elizabeth M Hecht
Review Article: Imaging in Medicine
-
Update on liver MRI at 3T
Sriyesh Krishnan and Elizabeth M Hecht
Review Article: Imaging in Medicine
-
Conference Scene 2:5
Erika Denton
News and Views: Imaging in Medicine
-
Conference Scene 2:5
Erika Denton
News and Views: Imaging in Medicine
Relevant Topics in General Science